Hippocratic AI announced several executive appointments to support the continued growth and responsible scaling of its generative AI healthcare agents. The additions follow the company’s $141 million Series C financing and are intended to strengthen clinical leadership, strategic execution, and go-to-market capabilities as adoption expands across providers, payors, and life sciences organizations. CEO Munjal Shah emphasized the importance of building a leadership team grounded in clinical credibility, operational rigor, and patient safety.
Dr. Anoop Sangha joins as Associate Chief Medical Officer, bringing more than 20 years of clinical and leadership experience across digital health and payor organizations, including Transcarent, Livongo, and Optum. Dr. Eduardo Reis joins the Office of the CEO as Vice President of Strategy, contributing expertise in medical imaging and AI from roles at Stanford AIMI and Hospital Israelita Albert Einstein. Niloy Sanyal joins as Chief Marketing Officer, with more than two decades of experience scaling healthcare and enterprise SaaS companies, including leadership roles at LeanTaaS, Omnicell, and GE Digital. Hippocratic AI has raised $404 million to date and focuses on building non-diagnostic, patient-facing AI agents designed to expand access and improve health outcomes.